Decitabine Versus Supportive Care in Adults With Advanced-stage MDS

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

November 30, 2002

Study Completion Date

April 30, 2003

Conditions
Myelodysplastic Syndrome
Interventions
DRUG

decitabine (5-aza-2'deoxycytidine)

Trial Locations (24)

Unknown

Alta Bates Comprehensive Cancer Center, Berkeley

City of Hope National Medical Center, Duarte

Scripps Clinic, Escondido

Loma Linda Univ. Cancer Center, Loma Linda

Univ. California San Francisco Medical School, San Francisco

University of Florida, Gainesville

H. Lee Moffitt Cancer Center, Tampa

James A. Haley Veteran's Hospital, Tampa

Rush Medical Center, Chicago

University of Illinois at Chicago, Chicago

Dana Farber Cancer Institute, Boston

New England Medical Center Hospital, Boston

University of Massachusetts Medical School, Worcester

VA Medical Center, Minneapolis

Washington Univ. School of Medicine, St Louis

Roswell Park Cancer Institute, Buffalo

Memorial Sloan Kettering Cancer Center, New York

Mount Sinai Medical Center, New York

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

Duke University Medical Center, Durham

The Memphis Cancer Center, Memphis

SW Regional Cancer Center (dba Central Texas Oncology Associates), Austin

Texas Oncology, Dallas

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY